Melexis Q3 2026 results

Regulated information

Intermediate declaration by the Board of Directors

Ieper, Belgium - October 28th, 2026, 07.00 hrs CET

Dear,

Please find herewith the link to our most recent press release: 

https://www.melexis.com/en/news/2026/financial/melexis-q3-2026-results

Attachment


Corporate news

Aspo to publish Interim Report on Monday, November 2, 2026
Borregaard ASA: All-time high EBITDA1 of NOK 557 million in the 3rd quarter
Gulf Businesses Risk Leaving Frontline Workers Behind in AI Transformation, Says Staffbase
Medidata Named by IDC MarketScape™ as a Leader in Worldwide Life Sciences R&D RWD/RWE Data Platforms, Technology Solutions, and Consulting Services
Hepsor AS consolidated unaudited interim report for Q3 2026 and nine months
Roche strengthens cancer diagnostic portfolio with launch of test for differential diagnosis of mesothelioma
Arcadis Q3 2026 Trading Update: Accelerating growth and improved profitability
Corbion delivers strong volume-led sales growth and significant margin improvement in Q3; full-year guidance maintained
Returns European stocks
Crypto currencies information
About us Network Partners
Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos Analist.nlLinksISIN
  • Glossary
    		• MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
    ©2026 ValueSpectrum. All Rights Reserved
    Developed and maintained by